Literature DB >> 19168098

Membrane localization of RasGRP1 is controlled by an EF-hand, and by the GEF domain.

Ghazaleh Tazmini1, Nadine Beaulieu, Ada Woo, Bari Zahedi, Rebecca E Goulding, Robert J Kay.   

Abstract

RasGRP1 is an exchange factor for membrane-localized Ras GTPases. Activation of RasGRP1 requires its translocation to membranes, which can be directly mediated by either its PT or C1 domains. RasGRP1 also has a pair of EF-hands which have been proposed to regulate RasGRP1 by sensing receptor-induced calcium fluxes. We determined that one of these EF-hands, EF1, is required for receptor-induced translocation of RasGRP1 to the plasma membrane in B cell lines. EF1 enables plasma membrane targeting of RasGRP1 by counteracting the SuPT domain, a negative regulator of the PT domain. Contrary to expectations, EF1-mediated translocation of RasGRP1 does not involve antigen receptor-induced intracellular calcium flux. Instead, alternative splicing affecting EF1 serves to modulate RasGRP1 localization. Excision of an exon encoding part of EF1 selectively disables PT domain-mediated plasma membrane targeting of RasGRP1, without affecting C1 domain-mediated localization to endomembranes. While EF1 specifically controls PT-mediated plasma membrane targeting, the Ras binding site in the catalytic GEF domain of RasGRP1 is required for both PT-mediated plasma membrane targeting and C1-mediated localization to endomembranes. Positive feedback between its GEF domain and membrane-binding domains could be important for full activation of RasGRP1, with occupation of the Ras binding sites in the GEF domain resulting in functional liberation of the PT and C1 domains, and membrane binding by these domains serving to maintain the Ras-GEF interaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19168098     DOI: 10.1016/j.bbamcr.2008.12.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Phosphoinositide 3-kinase regulates plasma membrane targeting of the Ras-specific exchange factor RasGRP1.

Authors:  Bari Zahedi; Hyun-Jung Goo; Nadine Beaulieu; Ghazaleh Tazmini; Robert J Kay; Rosemary B Cornell
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

2.  Regulation of the Small GTPase Ras and Its Relevance to Human Disease.

Authors:  Kayla R Kulhanek; Jeroen P Roose; Ignacio Rubio
Journal:  Methods Mol Biol       Date:  2021

3.  A RasGRP, C. elegans RGEF-1b, couples external stimuli to behavior by activating LET-60 (Ras) in sensory neurons.

Authors:  Lu Chen; Ya Fu; Min Ren; Bing Xiao; Charles S Rubin
Journal:  Neuron       Date:  2011-04-14       Impact factor: 17.173

4.  Importance of the REM (Ras exchange) domain for membrane interactions by RasGRP3.

Authors:  Agnes Czikora; Noemi Kedei; Heather Kalish; Peter M Blumberg
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-09-11       Impact factor: 3.747

5.  Ca-dependent Ras/Erk signaling mediates negative selection of autoreactive B cells.

Authors:  Andre Limnander; Arthur Weiss
Journal:  Small GTPases       Date:  2011-09-01

6.  Regulation and Function of the RasGRP Family of Ras Activators in Blood Cells.

Authors:  James C Stone
Journal:  Genes Cancer       Date:  2011-03

7.  RasGRP Ras guanine nucleotide exchange factors in cancer.

Authors:  Olga Ksionda; Andre Limnander; Jeroen P Roose
Journal:  Front Biol (Beijing)       Date:  2013-10-01

8.  Regulation of RasGRP1 function in T cell development and activation by its unique tail domain.

Authors:  Deirdre M Fuller; Minghua Zhu; Xiaohua Song; Chih-wen Ou-Yang; Sarah A Sullivan; James C Stone; Weiguo Zhang
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

9.  The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral.

Authors:  K Osei-Sarfo; L Martello; S Ibrahim; A Pellicer
Journal:  Oncogene       Date:  2011-03-28       Impact factor: 9.867

10.  Structural analysis of autoinhibition in the Ras-specific exchange factor RasGRP1.

Authors:  Jeffrey S Iwig; Yvonne Vercoulen; Rahul Das; Tiago Barros; Andre Limnander; Yan Che; Jeffrey G Pelton; David E Wemmer; Jeroen P Roose; John Kuriyan
Journal:  Elife       Date:  2013-07-30       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.